Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rinku General Medical Center (RGMC) is a premier tertiary healthcare institution located in Izumisano, Osaka, Japan, strategically positioned near Kansai International Airport. As one of only four designated Specific Infectious Disease Hospitals in Japan, it plays a pivotal role in national and international health security and pandemic preparedness. The center offers a wide array of specialized medical services, including a high-level emergency and critical care center, advanced oncology treatments, and comprehensive cardiovascular care. RGMC is operated by the Izumisano City Hospital Organization and serves as a vital teaching hospital, contributing to clinical research and medical education. Its facilities are equipped with sophisticated medical technology to support its mission as a regional disaster medical center. The institution is dedicated to providing high-quality, patient-centered care to the southern Osaka metropolitan area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rinku General Medical Centre.